Analyst consensus — VIRBAC
FR0000031577 · Pharmaceuticals & Biotechnology
Current price
378,50 €
Median target
417,50 €
Gap
+10,3%
Low target
368,00 €
High target
440,00 €
30-day trend
≈ -0,6%
Consensus
Buy (66.7%), Outperform (33.3%)
Latest banks : TP Icap Midcap (19/03/2026), BNP Paribas Exane (22/01/2026), IDMidcaps (21/01/2026)
Consensus evolution
| Period | Median target | Consensus |
|---|---|---|
| Today | 417,50 € | Buy (66.7%), Outperform (33.3%) |
| 7 days ago | 420,00 € | Buy (66.7%), Outperform (33.3%) |
| 14 days ago | 420,00 € | Buy (66.7%), Outperform (33.3%) |
| 21 days ago | 420,00 € | Buy (66.7%), Outperform (33.3%) |
Some analysts
| Analyst | Target | Rating | Date |
|---|---|---|---|
| TP Icap Midcap | 407,00 € | Buy | Mar 19, 2026 |
| BNP Paribas Exane | 440,00 € | Outperform | Jan 22, 2026 |
| IDMidcaps | 420,00 € | Buy | Jan 21, 2026 |
Gratuit · Chaque matin
Les signaux techniques du marché, avant l'ouverture.
Dynamiques haussières et baissières, changements d'analystes, valeurs à surveiller — calculés automatiquement sur les données Euronext.
✓ Avant 9h chaque matin
✓ Données Euronext
✓ Analyse automatique IA
Données indicatives. Aucun conseil en investissement. Désinscription à tout moment.
